Contrasting BioLargo (BLGO) and Its Competitors

BioLargo (NASDAQ:BLGO – Get Free Report) is one of 34 publicly-traded companies in the “Chemicals & allied products” industry, but how does it contrast to its peers? We will compare BioLargo to related businesses based on the strength of its profitability, institutional ownership, valuation, analyst recommendations, risk, dividends and earnings. Analyst Ratings This is a […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI) Price Target at $10.25
Next post Concentrix Co. (NASDAQ:CNXC) Given Consensus Recommendation of “Buy” by Brokerages